The Alzheimer’s Drug Discovery Foundation and Charles River Collaborate to Create a New Cognitive Aging Research Program
Saturday, July 16th, 2011NEW YORK and WILMINGTON, Mass., July 12, 2011 /PRNewswire-USNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF) is pleased to announce a collaboration with Charles River Laboratories International, Inc. (NYSE: CRL), a leading provider of early-stage drug development products and services, for the creation of a new research award program entitled ... continue reading